日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and Pharmacokinetics of Repeat Dosing of Long-Acting SARS-CoV-2 Antibodies Tixagevimab/Cilgavimab (AZD7442): Results from the PROVENT Sub-study

长效SARS-CoV-2抗体Tixagevimab/Cilgavimab (AZD7442)重复给药的安全性和药代动力学:PROVENT子研究结果

Ustianowski, Andrew; Levin, Myron J; De Wit, Stephane; Launay, Odile; Veekmans, Bernard; Rampling, Tommy; Sullivan, James G; Vishnepolsky, Mark; Wijewardane, Priyantha; Fawadleh, Yousef; Zhang, Huixia; Li, Meng; Wickramarachchi, Dilki; Sharbaugh, Audrey; Beavon, Rohini; Thissen, Jesse; Hirao, Lauren; Dzutseva, Vitalina; Seegobin, Seth; Streicher, Katie; Kiazand, Alexandre; Esser, Mark T; Chang, Lee-Jah; Perez, John L; Cohen, Taylor S

A SARS-CoV-2 variant‑adjusted threshold of protection model for monoclonal antibody pre-exposure prophylaxis against COVID-19

基于SARS-CoV-2变异株调整的单克隆抗体暴露前预防COVID-19的保护阈值模型

Edge, Rhiannon; Matthews, Sam; Ahani, Bahar; Aksyuk, Anastasia A; Clegg, Lindsay; Perez, John L; Esser, Mark T; Chang, Lee-Jah; Hirsch, Ian; Villafana, Tonya; Pura, John; Stepanov, Oleg; Streicher, Katie; White, Tom; Cohen, Taylor S; Follmann, Dean; Gilbert, Peter B; Seegobin, Seth

Dual action tofacitinib-loaded PLGA nanoparticles alleviate colitis in an IBD mouse model

载有托法替尼的双效PLGA纳米颗粒可缓解IBD小鼠模型中的结肠炎

Seegobin, Nidhi; McCoubrey, Laura E; Vignal, Cécile; Waxin, Christophe; Abdalla, Youssef; Fan, Yue; Awad, Atheer; Murdan, Sudaxshina; Basit, Abdul W

Direct-Acting Oral Anticoagulants in the Management of Cerebral Venous Sinus Thrombosis-Where Do We Stand?

直接口服抗凝剂在脑静脉窦血栓形成治疗中的应用现状如何?

Vojjala, Nikhil; Peshin, Supriya; Kattamuri, Lakshmi Prasanna Vaishnavi; Iqbal, Rabia; Dharia, Adit; Jayakumar, Jayalekshmi; Iftekhar, Rafi; Singh, Shagun; Balla, Mamtha; Villa Celi, Claudia S; Ramachandran, Ramya; Prabhu, Rishab; Yadav, Sumeet K; Krishnamoorthy, Geetha; Singh, Vijendra; Seegobin, Karan

Single-cell profiling of brain pericyte heterogeneity following ischemic stroke unveils distinct pericyte subtype-targeted neural reprogramming potential and its underlying mechanisms

缺血性卒中后脑周细胞异质性的单细胞分析揭示了不同周细胞亚型靶向神经重编程潜能及其潜在机制。

Allison Loan ,Nidaa Awaja ,Margarita Lui ,Charvi Syal ,Yiren Sun ,Sailendra N Sarma ,Ragav Chona ,William B Johnston ,Alex Cordova ,Devansh Saraf ,Anabella Nakhlé ,Kaela O'Connor ,Jacob Thomas ,Joseph Leung ,Matthew Seegobin ,Ling He ,Fredric E Wondisford ,David J Picketts ,Eve C Tsai ,Hing Man Chan ,Jing Wang

Safety, Efficacy and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Treatment of Mild-to-Moderate COVID-19: 15-Month Final Analysis of the TACKLE Trial

AZD7442(Tixagevimab/Cilgavimab)治疗轻度至中度COVID-19的安全性、有效性和药代动力学:TACKLE试验的15个月最终分析

Hobbs, F D Richard; Montgomery, Hugh; Padilla, Francisco; Simón-Campos, Jesus Abraham; Arbetter, Douglas; Seegobin, Seth; Kiazand, Alexandre; Streicher, Katie; Martinez-Alier, Nuria; Cohen, Taylor S; Esser, Mark T

Efficacy, Safety, and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Prevention of Symptomatic COVID-19: 15-Month Final Analysis of the PROVENT and STORM CHASER Trials

AZD7442(Tixagevimab/Cilgavimab)预防有症状COVID-19的疗效、安全性和药代动力学:PROVENT和STORM CHASER试验的15个月最终分析

Levin, Myron J; Ustianowski, Andrew; De Wit, Stephane; Beavon, Rohini; Thissen, Jesse; Seegobin, Seth; Dey, Kanika; Near, Karen A; Streicher, Katie; Kiazand, Alexandre; Esser, Mark T

Serum AZD7442 (tixagevimab-cilgavimab) concentrations and in vitroIC(50) values predict SARS-CoV-2 neutralising antibody titres

血清AZD7442(tixagevimab-cilgavimab)浓度和体外IC(50)值可预测SARS-CoV-2中和抗体滴度

Clegg, Lindsay E; Stepanov, Oleg; Matthews, Sam; White, Tom; Seegobin, Seth; Thomas, Steven; Tuffy, Kevin M; Någård, Mats; Esser, Mark T; Streicher, Katie; Cohen, Taylor S; Aksyuk, Anastasia A

Autophagy enables microglia to engage amyloid plaques and prevents microglial senescence

自噬使小胶质细胞能够与淀粉样斑块相互作用并防止小胶质细胞衰老。

Insup Choi ,Minghui Wang ,Seungyeul Yoo ,Peng Xu ,Steven P Seegobin ,Xianting Li ,Xian Han ,Qian Wang ,Junmin Peng ,Bin Zhang ,Zhenyu Yue

AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019

AZD7442(Tixagevimab/Cilgavimab)用于2019冠状病毒病症状暴露后预防

Levin, Myron J; Ustianowski, Andrew; Thomas, Steven; Templeton, Alison; Yuan, Yuan; Seegobin, Seth; Houlihan, Catherine F; Menendez-Perez, Ibrahim; Pollett, Simon; Arends, Rosalinda H; Beavon, Rohini; Dey, Kanika; Garbes, Pedro; Kelly, Elizabeth J; Koh, Gavin C K W; Ivanov, Stefan; Near, Karen A; Sharbaugh, Audrey; Streicher, Katie; Pangalos, Menelas N; Esser, Mark T